Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether the topical use of lidocaine spray 10% on the cervix is an effective way to reduce pain during IUCD insertion.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01496105
Study type Interventional
Source Ain Shams University
Contact Mohamed S.Eldin Elsafty, Lecturer
Phone +201003922211
Email emeira2@gmail.com
Status Recruiting
Phase Phase 4
Start date July 2011
Completion date January 2012

See also
  Status Clinical Trial Phase
Recruiting NCT06020391 - Cooperation for Better Treatment of Polypharmacy in the Community N/A
Completed NCT02490345 - Gabapentin as Adjunctive Treatment for Postoperative Pain Control Phase 1
Completed NCT01931683 - Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA) Phase 4
Withdrawn NCT03938077 - A Community-University Approach to Preventing HIV N/A
Completed NCT02973724 - EC95 of Remifentanil for Preventing Cough N/A
Completed NCT01152970 - F.Y.I.: Flint Youth Injury Study N/A
Completed NCT03330782 - Remifentanil for Preventing Propofol Injection Pain in Elderly Patients Phase 4
Completed NCT01489683 - Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine N/A
Completed NCT03368456 - Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention N/A
Completed NCT02379455 - Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Study N/A
Completed NCT01852539 - Dexmedetomidine for Laryngeal Mask Airway Insertion Phase 4
Completed NCT01963130 - Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study N/A
Completed NCT02334046 - Remifentanil for Smooth Emergence in Elderly Patients Phase 4
Completed NCT00876941 - Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use Phase 3